Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04809363 · ClinicalTrials.gov registry record · Phase 4

A Study of CDPATH™ to Help Manage and Treat Crohn's Disease

A Phase 4 study of Crohn's Disease, sponsored by Takeda.

Active
Registry status
Phase 4
Development phase
200
Enrollment target
20
Study locations

NCT04809363 is a Phase 4 study of Crohn's Disease that is active but no longer recruiting, run by Takeda. The registered enrollment target is 200 participants, below the 2,413-participant average among 104 other Crohn's Disease trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04809363, a Phase 4 study of Crohn's Disease, is active but no longer recruiting, sponsored by Takeda.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
200 participants
Enrollment target
20
Study locations

Study Summary

CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. The main aim of the study is to explore the use of CDPATH™ to describe a participant's risk profile and to have discussions with their doctor about the potential path of their Crohn's disease. The number of visits will be decided by the study clinic according to their standard practice.

Conditions Studied

Crohn's Disease

Interventions

  • OTHER Blood Draw
  • OTHER CDPATH™

Study Locations (20)

California

  • VA Loma Linda Healthcare System - Loma Linda
  • United Medical Doctors - Murrieta
  • University of Southern California Medical Center - Newport Beach
  • Clinnova Research Solutions - Orange
  • University of California at Irvine Medical Center - Orange

Illinois

  • GI Alliance - Arlington Heights
  • GI Alliance - Gurnee
  • Comprehensive Gastrointestinal Health - Northbrook
  • Rockford Gastroenterology Associates, Ltd. - Rockford

Florida

  • West Central Gastroenterology d/b/a Gastro Florida - Clearwater
  • Gastroenterology Associates of Pensacola, PA - Pensacola

Iowa

  • Iowa Digestive Disease Center - Clive
  • University of Iowa Hospitals & Clinics - Iowa City

Arizona

  • Arizona Arthritis & Rheumatology Research, PLLC - Phoenix

Colorado

  • Kaiser Permanate of Colorado - Aurora

Connecticut

  • Medical Research Center of Connecticut, LLC - Hamden

Idaho

  • Grand Teton Research Group, PLL - Idaho Falls

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-06-25
Est. Completion 2026-09-12
Phase Phase 4

Sponsor

Takeda

408 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04809363

The ClinicalTrials.gov registry entry for NCT04809363 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,413-participant average among 104 other Crohn's Disease trials with a reported enrollment target (92% lower). The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Crohn's Disease appearing as the primary indexed condition, and to 2 interventions - of which Blood Draw is the first listed.

NCT04809363 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Illinois, Florida.

Frequently Asked Questions

What is clinical trial NCT04809363 about?

NCT04809363 is a clinical study titled "A Study of CDPATH™ to Help Manage and Treat Crohn's Disease". CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. The main aim of the study is to explore the use of CDPATH™ to describe a participant's risk profile and to have discussions with their doctor about the p...

What is the current status of trial NCT04809363?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 200 participants. The study started on 2021-06-25. Estimated completion is 2026-09-12.

What conditions does trial NCT04809363 study?

This clinical trial studies the following conditions: Crohn's Disease.

What interventions are being tested in trial NCT04809363?

The interventions under investigation include: Blood Draw (OTHER), CDPATH™ (OTHER).

Who is sponsoring clinical trial NCT04809363?

This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04809363 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Connecticut, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Crohn's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Crohn's Disease

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.